Helix BioPharma Ratios and Metrics

Market cap in millions CAD. Fiscal year is August - July.

Millions CAD. Fiscal year is Aug - Jul.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 16, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021
Market Cap	114	79	56	42	33	117
Market Cap Growth	130.79%	40.75%	34.21%	28.68%	-72.14%	63.18%
Enterprise Value	111.32	79.62	55.29	41.2	31.86	117.19
Last Close Price	1.45	1.07	1.15	1.05	0.95	4.15
PB Ratio	7.75	5.09	-626.39	-49.77	102.32	-84.09
P/TBV Ratio	-	-	-	-	97.76	-
Debt / Equity Ratio	0.02	0.02	0	0	0	-1.14
Net Debt / Equity Ratio	-0.17	0.02	12.01	0.96	-2.46	-0.03
Net Debt / EBITDA Ratio	0.78	-0.05	0.12	0.13	0.13	0.00
Net Debt / FCF Ratio	0.77	-0.07	0.21	0.15	0.12	0.00
Quick Ratio	0.43	0.06	0.72	0.46	1.03	1.01
Current Ratio	0.45	0.13	0.92	0.53	1.08	1.04
Return on Equity (ROE)	-20.64%	-63.64%	1962.74%	2396.19%	1222.53%	-1205.79%
Return on Assets (ROA)	-15.74%	-51.85%	-729.94%	-265.80%	-154.98%	-203.57%
Return on Invested Capital (ROIC)	-15.47%	-56.07%	-1727.44%	-357.91%	-263.86%	-722.10%
Return on Capital Employed (ROCE)	-20.71%	-67.89%	1965.78%	2405.32%	-2369.02%	-575.73%
Buyback Yield / Dilution	-46.69%	-25.53%	-11.03%	-19.76%	-22.51%	-4.90%
Total Shareholder Return	-46.69%	-25.53%	-11.03%	-19.76%	-22.51%	-4.90%